The choice of therapy for patients with irritable bowel syndrome (IBS) has been based on the predominant bowel symptom; however, it has proven difficult to identify any optimal single pharmacological therapeutic targets. This Review summarizes current and future therapeutic strategies for the treatment of IBS on the basis of putative pathophysiological models.
- Filippo Cremonini
- Nicholas J Talley